Pharmacists Expand Access to Reproductive heaLthcare

Study Overview
=================
Brief Summary
-----------------
Prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates, as well as measures of safety and acceptability.

Detailed Description
-----------------
Direct prescription of hormonal contraception (HC) by pharmacists, without a doctor's visit or medical prescription, is a strategy to improve access to contraception and reduce unintended pregnancy. Oregon is the first state in the nation to implement legislation, as of January 1, 2016, expanding the scope of pharmacists to prescribe short-acting HCs. House Bill (HB) 2879 allows pharmacists to directly prescribe HC including the patch and pill, without a medical prescription. Women over 18 years of age can either initiate or continue HCs with a pharmacist, and women under 18 can continue a prescription. This prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist, aims to determine contraceptive continuation and incident pregnancy rates between women receiving hormonal contraception from a pharmacist versus other prescriber. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates.

Official Title
-----------------
Pharmacists Expand Access to Reproductive Healthcare: Reducing Unintended Pregnancy Through Pharmacist Prescription of Contraception

Conditions
-----------------
Contraception

Intervention / Treatment
-----------------
* Other: Pharmacist prescription
* Other: Clinician prescription


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Women presenting to initiate hormonal contraception at a study pharmacy Exclusion Criteria: Pregnancy Contraindications to hormonal contraception Under 18 years of age Unable or unwilling to consent

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 51 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Pharmacist prescription<br> | Other: Pharmacist prescription<br>* Pharmacist prescribed hormonal contraception (initiation or continuation).<br>|
| Clinician prescription<br> | Other: Clinician prescription<br>* Clinician prescribed hormonal contraception (initiation or continuation).<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Contraceptive continuation rates | Percentage of contraceptive continuation assessed through survey at 12 months among women who present for contraception in pharmacies. | 12 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Hormonal Contraception, Birth Control, Pharmacists